Skip to main content
. 2019 Feb 5;123(6):959–967. doi: 10.1111/bju.14673

Figure 2.

Figure 2

Decision‐curve analysis assessing the clinical impact of the nomograms estimating the prediction of bladder cancer (BCa) (A) and high‐risk BCa (B) in the follow‐up of patients with previous non‐muscle‐invasive BCa. The inclusion of EpiScore is compared with current clinical prognostic models and the strategies of evaluating all or none of the patients with cystoscopy and cytology.